Lista de obras - James Lilleker - Dominio Público Uruguay

A missense mutation in DYNC1H1 gene causing spinal muscular atrophy - Lower extremity, dominant.

artículo científico publicado en 2017

Advances in the early diagnosis and therapy of inclusion body myositis

artículo científico publicado en 2018

Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activity

artículo científico publicado en 2015

Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.

artículo científico publicado en 2017

Fibrous myopathy induced by intramuscular injections of cyclizine

artículo científico publicado en 2020

Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients

scientific article published on 13 April 2019

Genetics in inclusion body myositis.

artículo científico publicado en 2017

Glutamic acid decarboxylase (GAD) antibodies in epilepsy: diagnostic yield and therapeutic implications

artículo científico publicado en 2014

Idiopathic inflammatory myopathies - a guide to subtypes, diagnostic approach and treatment

artículo científico publicado en 2017

Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum

artículo científico publicado en 2017

Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria

artículo científico publicado en 2019

Insights into the knowledge, attitude and practices for the treatment of idiopathic inflammatory myopathy from a cross-sectional cohort survey of physicians

artículo científico publicado en 2020

Line blot immunoassays in idiopathic inflammatory myopathies: retrospective review of diagnostic accuracy and factors predicting true positive results

artículo científico publicado en 2020

Long-term strength and functional status in inclusion body myositis and identification of trajectory subgroups

artículo científico publicado en 2020

Metabolic myopathies: a practical approach

artículo científico publicado en 2017

Missense mutation in the ITPR1 gene presenting with ataxic cerebral palsy: Description of an affected family and literature review

artículo científico publicado en 2017

Neurogenic pulmonary oedema complicating a lateral medullary infarct

scientific article published on 26 July 2018

Neurological manifestations of influenza infection in children and adults: results of a National British Surveillance Study

artículo científico publicado en 2013

Paroxysmal dysarthria ataxia syndrome responds to lacosamide

artículo científico publicado en 2014

Patient-centred standards of care for adults with myositis

scientific article published on 28 November 2017

Prophylactic anticoagulation in Guillain-Barré syndrome: too much of a good thing?

artículo científico publicado en 2015

Rapamycin for inclusion body myositis: targeting non-inflammatory mechanisms

artículo científico publicado en 2019

Respiratory failure in clustered acetylcholine receptor autoantibody-positive myasthenia gravis

artículo científico publicado en 2019

Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagna et al.

artículo científico publicado en 2017

Selected aspects of the current management of myositis

artículo científico publicado en 2016

The EuroMyositis registry: an international collaborative tool to facilitate myositis research.

artículo científico

The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort.

artículo científico publicado en 2019

The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies

artículo científico publicado en 2016

Transient focal leukoencephalopathy with cerebral oedema as a presentation of cerebral amyloid angiopathy

artículo científico publicado en 2016

Using serum troponins to screen for cardiac involvement and assess disease activity in the idiopathic inflammatory myopathies.

artículo científico publicado en 2018

[18F]Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis

artículo científico publicado en 2019

Lista de obras de James Lilleker

A missense mutation in DYNC1H1 gene causing spinal muscular atrophy - Lower extremity, dominant.

Advances in the early diagnosis and therapy of inclusion body myositis

Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activity

Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.

Fibrous myopathy induced by intramuscular injections of cyclizine

Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients

Genetics in inclusion body myositis.

Glutamic acid decarboxylase (GAD) antibodies in epilepsy: diagnostic yield and therapeutic implications

Idiopathic inflammatory myopathies - a guide to subtypes, diagnostic approach and treatment

Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum

Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria

Insights into the knowledge, attitude and practices for the treatment of idiopathic inflammatory myopathy from a cross-sectional cohort survey of physicians

Line blot immunoassays in idiopathic inflammatory myopathies: retrospective review of diagnostic accuracy and factors predicting true positive results

Long-term strength and functional status in inclusion body myositis and identification of trajectory subgroups

Metabolic myopathies: a practical approach

Missense mutation in the ITPR1 gene presenting with ataxic cerebral palsy: Description of an affected family and literature review

Neurogenic pulmonary oedema complicating a lateral medullary infarct

Neurological manifestations of influenza infection in children and adults: results of a National British Surveillance Study

Paroxysmal dysarthria ataxia syndrome responds to lacosamide

Patient-centred standards of care for adults with myositis

Prophylactic anticoagulation in Guillain-Barré syndrome: too much of a good thing?

Rapamycin for inclusion body myositis: targeting non-inflammatory mechanisms

Respiratory failure in clustered acetylcholine receptor autoantibody-positive myasthenia gravis

Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagna et al.

Selected aspects of the current management of myositis

The EuroMyositis registry: an international collaborative tool to facilitate myositis research.

The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort.

The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies

Transient focal leukoencephalopathy with cerebral oedema as a presentation of cerebral amyloid angiopathy

Using serum troponins to screen for cardiac involvement and assess disease activity in the idiopathic inflammatory myopathies.

[18F]Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis